Collecting data is of paramount importance when trying to understand a disease that little is know about. Ciox, a health technology company, is working with LabCorp to analyze data in order to be better prepared for a future outbreak or pandemic, CEO and President of Real World Data Divisions Stephen Kahane told Invest: Insights. They are looking into the efficiency of different therapies incorporating variable such as socioeconomic background, while also looking into immunity and asymptomatic cases.
